Efficacy, safety and impact on antimicrobial resistance of duration and dose of amoxicillin treatment for young children with Community-Acquired Pneumonia: a protocol for a randomIsed controlled Trial (CAP-IT). (2019)

First Author: Lyttle MD
Attributed to:  Other infectious diseases of global public health significance funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/bmjopen-2019-029875

PubMed Identifier: 31123008

Publication URI: http://europepmc.org/abstract/MED/31123008

Type: Journal Article/Review

Volume: 9

Parent Publication: BMJ open

Issue: 5

ISSN: 2044-6055